Formic Acid

Formic Acid

SCHEMBL6691

Cl.O=CO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Formic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL29418891 1.00
Formic Acid SCHEMBL29301 1.00
Formic Acid SCHEMBL23420519 1.00
Formic Acid SCHEMBL11389712 0.94
Formic Acid SCHEMBL9477283 0.94
Formic Acid SCHEMBL9449497 0.94
Formic Acid SCHEMBL4678172 0.94
Formic Acid SCHEMBL5995205 0.94
Formic Acid SCHEMBL25389190 0.94
Formic Acid SCHEMBL11557232 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 17100 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119684285-A Inhibition of cyclic AMP-responsive element binding proteins (CREB) 福马治疗股份有限公司 2025-03-25 CN claimed
CN-118834124-B Synthesis method of trans-2-octenal 济南悟通生物科技有限公司 2024-11-26 CN claimed
CN-118834124-A Synthesis method of trans-2-octenal 济南悟通生物科技有限公司 2024-10-25 CN claimed
WO-2024150812-A1 COMPOSITION FOR ELECTRODE FORMATION, ADDITIVE, AND GELATION INHIBITOR 日産化学株式会社 2024-07-18 WO claimed
WO-2024150813-A1 COMPOSITION FOR ELECTRODE FORMATION AND ADDITIVE 日産化学株式会社 2024-07-18 WO claimed
WO-2024150450-A1 COMPOSITION FOR ELECTRODE FORMATION, ADDITIVE, AND GELATION INHIBITOR 日産化学株式会社 2024-07-18 WO claimed
WO-2024150446-A1 COMPOSITION FOR ELECTRODE FORMATION 日産化学株式会社 2024-07-18 WO claimed
WO-2024150479-A1 COMPOSITION FOR ELECTRODE FORMATION, ADDITIVE, AND GELATION INHIBITOR 日産化学株式会社 2024-07-18 WO claimed
US-12030774-B2 Surface-modified inorganic nitride, composition, thermally conductive material, and device with thermally conductive layer FUJIFILM CORPORATION (JP) 2024-07-09 US claimed
WO-2024142035-A1 PROCESS FOR THE PREPARATION OF BIGUANIDINES AND TRIAZINES ADAMA AGAN LTD. (IL) 2024-07-04 WO claimed
US-4104300-A MOLYBDENUM CATALYST, COMPLEXING AGENT DYNAMIT NOBEL AKTIENGESELLSCHAFT (DE) 1978-08-01 US claimed
US-4080378-A REACTING A CARBOXYLIC ACID ESTER WITH A TRICHLOROMETHYL SUBSTITUTED AROMATIC COMPOUND IN THE PRESENCE OF A MOLYBDENUM CATALYST DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) 1978-03-21 US claimed
US-4080377-A Production of cyclic five-membered ring unsaturated phosphine dichlorides BAYER AKTIENGESELLSCHAFT (DT) 1978-03-21 US claimed
US-4069257-A THERMAL DECOMPOSITION OF 2-METHYL-3-HYDROXYMETHYLPENT-1-ENE-4-ONE OR ESTER THEROF BAYER AKTIENGESELLSCHAFT (DT) 1978-01-17 US claimed
US-4058646-A HIGH SURFACE HARDNESS BASF AKTIENGESELLSCHAFT (DT) 1977-11-15 US claimed
US-4048166-A MICROBIOCIDES THE DOW CHEMICAL COMPANY (US) 1977-09-13 US claimed
US-4036877-A Process for the production of aldehydes BUDAPESTI MUSZAKI EGYETEM (HU) 1977-07-19 US claimed
US-3962326-A CARBOXYLIC ACID OR ANHYDRIDE, PHOSGENE, TRISUBSTITUTED PHOSPHINE OXIDE OR SULFIDE HOECHST AKTIENGESELLSCHAFT (DT) 1976-06-08 US claimed
US-3962344-A Process for making 1,3-diene hydrocarbons GIVAUDAN CORPORATION (US) 1976-06-08 US claimed
US-3957815-A 3-[3',4'-Dichloro-6'-alkyl-phenyl]-Δ2 -pyrazoline derivatives and their use as optical brighteners HOECHST AKTIENGESELLSCHAFT (DT) 1976-05-18 US claimed